Syros Pharmaceuticals appoints director
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Syros Pharmaceuticals Inc. appointed Srinivas Akkaraju to the company's board of directors.
Akkaraju is a founder and managing general partner at Samsara BioCapital and currently serves as chairman of Versartis Inc.